|
INN name:
|
Bexagliflozin
|
||||||
|
Lab codes:
|
EGT-0001442;
EGT-1442; THR-1442
|
||||||
|
Chemical name:
|
(1S)-1,5-anhydro-1-C-[4-chloro-3-({4-[2-(cyclopropyloxy)ethoxy]phenyl}methyl)phenyl]-D-glucitol
|
||||||
|
Molecular formula:
|
C24H29ClO7
|
||||||
|
Chemical Structure:
|
 |
||||||
|
CAS Registry Number:
|
1118567-05-7
|
||||||
|
Originator:
|
Theracos
|
||||||
|
Class:
|
Antidiabetic
|
||||||
|
Mechanism of Action:
|
Sodium-glucose
transporter 2 inhibitors
|
||||||
|
WHO ATC code:
|
A10X
(Other Drugs Used in Diabetes)
|
||||||
|
EPhMRA code:
|
A10X
(Other Drugs Used in Diabetes)
|
||||||
|
Clinical
Trials:
|
|||||||
|
Product
Patent Expiry:
For
patent data contact us at drugpatentexpiry@gmail.com
|
|||||||
Tuesday, 8 September 2015
Bexagliflozin
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment